Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8,956 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety, activity, and molecular heterogeneity following neoadjuvant non-pegylated liposomal doxorubicin, paclitaxel, trastuzumab, and pertuzumab in HER2-positive breast cancer (Opti-HER HEART): an open-label, single-group, multicenter, phase 2 trial.
Gavilá J, Oliveira M, Pascual T, Perez-Garcia J, Gonzàlez X, Canes J, Paré L, Calvo I, Ciruelos E, Muñoz M, Virizuela JA, Ruiz I, Andrés R, Perelló A, Martínez J, Morales S, Marín-Aguilera M, Martínez D, Quero JC, Llombart-Cussac A, Prat A. Gavilá J, et al. Among authors: martinez d, martinez j. BMC Med. 2019 Jan 9;17(1):8. doi: 10.1186/s12916-018-1233-1. BMC Med. 2019. PMID: 30621698 Free PMC article. Clinical Trial.
Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer.
Moore KN, Angelergues A, Konecny GE, García Y, Banerjee S, Lorusso D, Lee JY, Moroney JW, Colombo N, Roszak A, Tromp J, Myers T, Lee JW, Beiner M, Cosgrove CM, Cibula D, Martin LP, Sabatier R, Buscema J, Estévez-García P, Coffman L, Nicum S, Duska LR, Pignata S, Gálvez F, Wang Y, Method M, Berkenblit A, Bello Roufai D, Van Gorp T; Gynecologic Oncology Group Partners and the European Network of Gynaecological Oncological Trial Groups. Moore KN, et al. N Engl J Med. 2023 Dec 7;389(23):2162-2174. doi: 10.1056/NEJMoa2309169. N Engl J Med. 2023. PMID: 38055253 Clinical Trial.
Interval cytoredutive surgery and HIPEC in advanced ovarian cancer with small-bowel disease: results and reflections.
Cascales Campos PA, González Gil A, Gómez Ruiz ÁJ, Balaguer Román A, Gil Gómez E, Alconchel Gago F, Martínez J, Nieto Díaz A, Barceló Valcárcel F, Gil Martínez J. Cascales Campos PA, et al. Among authors: martinez j. Clin Transl Oncol. 2022 Aug;24(8):1542-1548. doi: 10.1007/s12094-022-02795-x. Epub 2022 Mar 10. Clin Transl Oncol. 2022. PMID: 35274202
Acute renal disease in patients with ovarian peritoneal carcinomatosis treated with cytoreduction and HIPEC: the influence of surgery and the cytostatic agent used.
Gómez-Ruiz ÁJ, González-Gil A, Gil J, Alconchel F, Navarro-Barrios Á, Gil-Gómez E, Martínez J, Nieto A, García-Palenciano C, Cascales-Campos PA. Gómez-Ruiz ÁJ, et al. Among authors: martinez j. Langenbecks Arch Surg. 2021 Nov;406(7):2449-2456. doi: 10.1007/s00423-021-02279-6. Epub 2021 Jul 20. Langenbecks Arch Surg. 2021. PMID: 34283300
Peritoneal Surface Disease Severity Score (PSDSS), AGO-score and TIAN model in patients with platinum-sensitive recurrent ovarian cancer treated by cytoreductive surgery plus HIPEC.
Gómez-Ruiz ÁJ, González-Gil A, Gil J, Navarro-Barrios Á, Alconchel F, Gil E, Martínez J, Nieto A, Barceló F, Cascales-Campos PA. Gómez-Ruiz ÁJ, et al. Among authors: martinez j. Clin Exp Metastasis. 2019 Oct;36(5):433-439. doi: 10.1007/s10585-019-09982-1. Epub 2019 Jul 3. Clin Exp Metastasis. 2019. PMID: 31270731
Prediction of serious complications in patients with seemingly stable febrile neutropenia: validation of the Clinical Index of Stable Febrile Neutropenia in a prospective cohort of patients from the FINITE study.
Carmona-Bayonas A, Jiménez-Fonseca P, Virizuela Echaburu J, Antonio M, Font C, Biosca M, Ramchandani A, Martínez J, Hernando Cubero J, Espinosa J, Martínez de Castro E, Ghanem I, Beato C, Blasco A, Garrido M, Bonilla Y, Mondéjar R, Arcusa Lanza MÁ, Aragón Manrique I, Manzano A, Sevillano E, Castañón E, Cardona M, Gallardo Martín E, Pérez Armillas Q, Sánchez Lasheras F, Ayala de la Peña F. Carmona-Bayonas A, et al. Among authors: martinez j, martinez de castro e. J Clin Oncol. 2015 Feb 10;33(5):465-71. doi: 10.1200/JCO.2014.57.2347. Epub 2015 Jan 5. J Clin Oncol. 2015. PMID: 25559804
Identifying the incidence of respiratory complications following diaphragmatic cytoreduction and hyperthermic intraoperative intraperitoneal chemotherapy.
Cascales Campos P, Martinez Insfran LA, Wallace D, Gil J, Gil E, Gonzalez Gil A, Martínez J, Alonso Romero JL, Gonzalez Sanchez R, Parrilla P. Cascales Campos P, et al. Among authors: martinez insfran la, martinez j. Clin Transl Oncol. 2020 Jun;22(6):852-859. doi: 10.1007/s12094-019-02195-8. Epub 2019 Aug 7. Clin Transl Oncol. 2020. PMID: 31392644
Long-term outcomes of spinal SBRT. Is it important to select the treatment time?
Pérez-Montero H, Godino O, Lozano A, Asiáin L, Martínez I, Sánchez JJ, de BlasFernández R, Fernández E, Stefanovic M, García N, Martínez J, Guedea F, Navarro-Martin A. Pérez-Montero H, et al. Among authors: martinez j, martinez i. Clin Transl Oncol. 2022 Feb;24(2):276-287. doi: 10.1007/s12094-021-02684-9. Epub 2021 Aug 3. Clin Transl Oncol. 2022. PMID: 34342817
8,956 results